| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/28/2002 | WO2001077080A3 Pyrazole compounds having anti proliferative activity |
| 02/28/2002 | WO2001056989A3 Inhibitors of factor xa |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026059 Use as microbicides in crop protection |
| 02/28/2002 | US20020026052 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease |
| 02/28/2002 | US20020026050 Thrombin receptor antagonists |
| 02/28/2002 | US20020025974 Hypotensive agents; vision defects |
| 02/28/2002 | US20020025961 Platelet ADP receptor inhibitors |
| 02/28/2002 | US20020025957 Anticoagulants, cardiovascular disorders |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | CA2415852A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | CA2415846A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/27/2002 | EP1182203A1 Azole compounds and herbicide compositions |
| 02/27/2002 | EP1182200A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 02/27/2002 | EP1182195A1 Cyclic compounds and uses thereof |
| 02/27/2002 | EP1182193A1 Remedies for neuropathic pain |
| 02/27/2002 | EP1182192A1 4-hydroxypiperidine derivatives having antiarrhythmic effect |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181275A1 Thio-oxindole derivatives |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors |
| 02/27/2002 | CN1337958A Compounds and methods for modulation of estroglen receptors |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases |
| 02/26/2002 | US6350775 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents |
| 02/26/2002 | US6350774 Antithrombotic agents |
| 02/26/2002 | US6350766 Pain, cns |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350720 Controlling weeds |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds |
| 02/21/2002 | WO2002014305A2 Design and synthesis of advanced nlo materials for electro-optic applications |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014279A1 New aporphine esters and their use in therapy |
| 02/21/2002 | WO2002014269A2 2,4-substituted pyridine derivatives |
| 02/21/2002 | WO2002013808A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022729 Pyridylfuran and pyridylthiophene compounds |
| 02/21/2002 | US20020022648 Novel 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | CA2419820A1 Design and synthesis of advanced nlo materials for electro-optic applications |
| 02/21/2002 | CA2418988A1 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1336369A Benzopyran compound, and its pharmaceutical use |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079396C Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/19/2002 | US6348480 Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348461 Central nervous system antagonist with heterocyclic substituents |
| 02/19/2002 | US6348435 Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | WO2002012187A1 Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors |
| 02/14/2002 | WO2002011724A2 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | US20020019541 For plants; fungicides |
| 02/14/2002 | US20020019533 Piperidine derivatives and anti-platelet agents containing the same |
| 02/14/2002 | US20020019530 Antitumor agent |
| 02/14/2002 | US20020019527 Antitumor, antcarcinogenic agents |
| 02/14/2002 | US20020019525 Pyrido [2,3-b] indolizine derivatives and aza analogues thereof; CRF1 specific ligands |
| 02/14/2002 | US20020019438 Respiratory system disorders |
| 02/14/2002 | US20020019436 Central nervous system disorders |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019408 New isoxazole-sulfonamide endothelin antagonists |
| 02/14/2002 | US20020019404 Anticancer agents, skin disorders |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020019383 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 02/14/2002 | CA2419030A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418912A1 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | CA2418083A1 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178985A1 Substituted thienocycloalk(en)ylamino-1,3,5-triazine |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP0942908B1 Thienylsulfonylamino(thio)carbonyl compounds |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | EP0711768B1 Benzimidazole derivative |
| 02/13/2002 | CN1335844A New 1,4-disubstituted cyclohexane derivatives for the treatment of depression |